BDR Pharma to acquire stake in Acme’s oral solid formulations business
The Hindu
BDR Pharma is set to acquire a stake in Acme's oral solid formulations business.
BDR Pharma has announced its plans to acquire a stake in the oral solid formulations business of Acme. The transaction involves business expansion and strategic alignment between the two pharmaceutical companies. Specific financial details and the exact percentage of the stake were not immediately detailed in the announcement.
Why it matters: This acquisition represents a strategic business consolidation within the pharmaceutical sector involving BDR Pharma and Acme.




